Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr;64(4):165-166.
doi: 10.3345/cep.2020.01277. Epub 2020 Sep 18.

Improving the lives of children with neurofibromatosis type 1

Yoo-Mi Kim  1
Affiliations
Editorial

Improving the lives of children with neurofibromatosis type 1

Yoo-Mi Kim. Clin Exp Pediatr. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
The pathogenesis (A) and onset of clinical features (B) of neurofibromatosis type 1 (NF1). AKT, protein kinase B; ERK, extracellular signal-regulated kinase; MEK, mitogen-activated protein kinase (MAPK)/ERK kinase; mTOR, mammalian target of rapamycin; PDK, 3-phosphoinositide-dependent protein kinase 1; PI3K, phosphatidylinositol 3-kinase; RAF, first identified downstream effector kinase of RAS.
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

References

    1. Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR, et al. Health supervision for children with neurofibromatosis type 1. Pediatrics. 2019;143:e20190660. - PubMed
    1. Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol. 2002;17:562–651. - PubMed
    1. Armstrong AE, Brossier NM, Hirbe AC. Neurofibromatosis type 1-related tumours in paediatrics: an evolving treatment landscape. Lancet Child Adolesc Health. 2020;4:488–90. - PubMed
    1. Allaway RJ, Gosline SJC, La Rosa S, Knight P, Bakker A, Guinney J, et al. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Br J Cancer. 2018;118:1539–48. - PMC - PubMed
    1. Wu-Chou YH, Hung TC, Lin YT, Cheng HW, Lin JL, Lin CH, et al. Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis. J Biomed Sci. 2018;25:72. - PMC - PubMed

LinkOut - more resources